TrialThe Journal of antimicrobial chemotherapy2022

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.

Simiso Sokhela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.